Uncategorized

Japan's Takeda Pharmaceutical is investing more than €100 million in a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.

BMJ Quality and Safety published a survey finding most primary care physicians do not fully disclose essential information to patients regarding a potentially harmful medical error, News-Medical reported.

Robert Pearl, MD, chairman of the Council of Accountable Physician Practices; CEO of The Permanente Medical Group; and president and CEO of the Mid-Atlantic Permanente Medical Group, delivered the keynote speech at the American Medical Group Association 2016 Institute for…

The Simulation Center at the Brody School of Medicine at East Carolina University in Greenville, N.C., offers medical students a chance to practice in a clinical setting, according to The East Carolinian.

The U.S. Senate Judiciary Committee had to postpone a hearing to discuss Mylan allegedly underpaying the government, according to Reuters.

The global hospital-acquired infection control market is expected to expand through 2020, a Persistence Market Research report found, according to medGadget.

Australian researchers found medication errors, although relatively common, may not have a serious impact on residents in skilled care settings, according to McKnight's.

San Francisco-based Stonerise Capital Management reduced its stake in Nashville, Tenn.-based Surgery Partners by 5.58 percent, according to Trade Calls.

Pennsylvania-based Mylan Pharmaceuticals' attorney sent a letter to Sen. Chuck Grassley (R-Iowa), chair of the Senate Judiciary Committee, saying the company will not testify at a Senate hearing on Nov. 30, 2016, according to STAT.

Inappropriate antibiotic prescribing is of increasing concern with at least 23,000 Americans dying from antibiotic-resistant bacteria each year.